Search

Home > GRACEcast Lung Cancer Video > Are there Clinically Significant Differences Among Immune Checkpoint Inhibitors Treating Lung Cancer?
Podcast: GRACEcast Lung Cancer Video
Episode:

Are there Clinically Significant Differences Among Immune Checkpoint Inhibitors Treating Lung Cancer?
Category: Science & Medicine
Duration: 00:02:54
Publish Date: 2015-11-04 14:00:00
Description:

Drs. Leora Horn, Ben Solomon, & Jack West consider whether the data suggest that the better tested PD1 and PD-L1 inhibitors have differences in activity or tolerability or are essentially interchangeable.
Total Play: 0